Skin-controlled release lipid nanosystems of pranoprofen for the treatment of local inflammation and pain
Abstract:
Aim: The design and development of pranoprofen (PF) nanostructured lipid carriers (NLCs) for topical treatment of local inflammation and pain. Materials & methods: PF-NLCs were designed and optimized by central rotatable composite design. A physicochemical characterization was addressed. Release and skin permeation were performed in Franz diffusion cells. In vivo anti-inflammatory efficacy was assayed in mice and tolerance study in humans. Results: PF-NLCs F7 and F10 provided sustained release, good stability and optimal skin retention avoiding systemic undesired side effects. Anti-inflammatory activity was enhanced, suggesting an improved efficacy as compared with standard formulation. No skin irritancy was detected. Conclusion: Topical PF-NLCs F7 and F10 could be effective and safe new therapeutic tools for the treatment of local inflammation and pain. </inline-graphic.
Año de publicación:
2018
Keywords:
- Anti-inflammatory efficacy
- Dermal delivery
- experimental design
- inflammation
- Local action
- nanostructured lipid carriers
- osteoarthritis
- Pranoprofen
- skin irritation
- Skin permeation
Fuente:
scopusTipo de documento:
Article
Estado:
Acceso restringido
Áreas de conocimiento:
- Inflamación
- Lípido
- Farmacología
Áreas temáticas de Dewey:
- Farmacología y terapéutica
- Enfermedades
- Fisiología humana
Objetivos de Desarrollo Sostenible:
- ODS 3: Salud y bienestar
- ODS 17: Alianzas para lograr los objetivos
- ODS 6: Agua limpia y saneamiento